维奈克拉联合多药化疗治疗复发难治早期前体T淋巴细胞白血病15例疗效及安全性分析

OBJECTIVE: To explore the efficacy and safety of Venetoclax combined with multidrug chemotherapy in patients with relapsed or refractory early T-cell precursor acute lymphoblastic leukemia（R/R ETP-ALL）. METHODS: This study retrospectively analyzed 15 patients with R/R ETP-ALL who received Venetoclax...

Descripción completa

Detalles Bibliográficos
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Editorial office of Chinese Journal of Hematology 2023
Materias:
论著
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10520236/
https://www.ncbi.nlm.nih.gov/pubmed/37803838
http://dx.doi.org/10.3760/cma.j.issn.0253-2727.2023.08.006

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10520236/
https://www.ncbi.nlm.nih.gov/pubmed/37803838
http://dx.doi.org/10.3760/cma.j.issn.0253-2727.2023.08.006

Ejemplares similares